Interpace Biosciences Inc SMA 200
What is the SMA 200 of Interpace Biosciences Inc?
The SMA 200 of Interpace Biosciences Inc is $1 +6.92%
What is the definition of SMA 200?
SMA 200 is an average stock price from the last 200 days calculated as an unweighted mean of the previous 200 stock closing prices.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 of companies in the Health Care sector on NASDAQ compared to Interpace Biosciences Inc
What does Interpace Biosciences Inc do?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Companies with sma 200 similar to Interpace Biosciences Inc
- Theratechnologies has SMA 200 of $1 -10.80%
- APM Human Services International has SMA 200 of AUD$1 +5.28%
- Jiashili has SMA 200 of HKD$1 -27.57%
- Titanium has SMA 200 of CAD$1 +28.16%
- Core One Labs has SMA 200 of $1 +68.62%
- MicroVision has SMA 200 of $1 -37.99%
- Interpace Biosciences Inc has SMA 200 of $1 +6.92%
- DarioHealth Corp has SMA 200 of $1 -73.25%
- Pipestone has SMA 200 of CAD$1 -92.96%
- Diaceutics Plc has SMA 200 of $1 -0.20%
- Energous Corp has SMA 200 of $1 -75.89%
- Lion Rock has SMA 200 of HKD$1 -0.92%
- Fiore Gold has SMA 200 of CAD$1 +1.90%